GENE ONLINE|News &
Opinion
Blog

Editors' Picks
Overcoming Immune Evasion in CAR-T Therapies with Groundbreaking New Discoveries
2022-09-22
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
The COVID-19 Pandemic: Is Omicron the Last Variant?
2022-09-16
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
Is Frozen-Thawed Embryo Transfer Associated with Increased Cancer Risk?
2022-09-16
Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy
2022-09-15Partner
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
Lactate’s Potential is an Immunotherapy Supplement for Cancer Treatments
2022-09-12
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
BIO CEO 2022: How Incubators Enable Biotech Startups
2022-03-01
BIO CEO: Overcoming the Obstacles in Developing Gene Therapies
2022-02-21
How Our Microbiomes Are Connected to Irritable Bowel Syndromes, Cancer and Autism: Highlights from the 6th Asia Microbiome Conference
2022-02-14
GeneOnline’s Pick: Novel Biotechnologies that Made a Splash in 2021
2022-01-27
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
GeneOnline’s Top 10 M&As of 2021
2022-01-11
1 2 3 9
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!